David Cohen
Directeur/Membre du Conseil chez TREX WIND-DOWN, INC.
Fortune : 1 $ au 31/03/2024
Profil
David Eric Cohen is currently an Independent Director at Kadmon Holdings, Inc., a Director at the American Dermatological Association, Inc., an Independent Director at Timber Pharmaceuticals, Inc., and a Director at Evommune, Inc. He previously held positions as a Professor at New York University and a Dermatology Professor at New York University School of Medicine.
In the past, he served as a Director at Connetics Corp., Vyteris, Inc., Brickell Subsidiary, Inc., Topica Pharmaceuticals, Inc., and the American Acne & Rosacea Society.
He was also an Independent Director at Dermira, Inc. from 2014 to 2020.
Additionally, he held roles as the President of the Dermatology Section at The New York Academy of Medicine, a Member of the American Academy of Dermatology, the Chief Resident of the Dermatology Department at NYU Langone Health, and the President of the American Contact Dermatitis Society.
Dr. Cohen's education includes a graduate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from City University of New York, a graduate degree from Joseph L.
Mailman School of Public Health, and a doctorate from Stony Brook University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TREX WIND DOWN INC
0,10% | 07/09/2023 | 3 366 ( 0,10% ) | 1 $ | 31/03/2024 |
Postes actifs de David Cohen
| Sociétés | Poste | Début |
|---|---|---|
| KADMON HOLDINGS, INC. | Directeur/Membre du Conseil | 07/02/2019 |
| TREX WIND-DOWN, INC. | Directeur/Membre du Conseil | 19/08/2020 |
| New York University | Corporate Officer/Principal | 16/08/2011 |
| New York University School of Medicine | Corporate Officer/Principal | 01/01/1993 |
American Dermatological Association, Inc.
 American Dermatological Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Dermatological Association, Inc. recognizes, discusses and develops solutions for problems in the area of dermatologic health care, research and education. The company was founded in 1876 and is headquartered in Fort Lauderdale, FL. | Directeur/Membre du Conseil | - |
Evommune, Inc.
 Evommune, Inc. Miscellaneous Commercial ServicesCommercial Services Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA. | Directeur/Membre du Conseil | 01/01/2020 |
Anciens postes connus de David Cohen
| Sociétés | Poste | Fin |
|---|---|---|
| DERMIRA, INC. | Directeur/Membre du Conseil | 20/02/2020 |
Vyteris, Inc.
 Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Directeur/Membre du Conseil | 01/01/2012 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Directeur/Membre du Conseil | 29/12/2006 |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ | - |
Formation de David Cohen
| City University of New York | Undergraduate Degree |
| Stony Brook University School of Medicine | Doctorate Degree |
| Joseph L. Mailman School of Public Health | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREX WIND-DOWN, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
| American Acne & Rosacea Society | |
Topica Pharmaceuticals, Inc.
 Topica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topica Pharmaceuticals, Inc. develops treatment for onychomycosis, or fungal infections of the nail and nail bed. Its prodycte, Luliconazole, a topical antifungal a topical antifungal agent used to tinea pedis. The company was founded in 2004 and is headquartered Los Altos, CA. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
American Dermatological Association, Inc.
American Dermatological Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Dermatological Association, Inc. recognizes, discusses and develops solutions for problems in the area of dermatologic health care, research and education. The company was founded in 1876 and is headquartered in Fort Lauderdale, FL. | Commercial Services |
American Contact Dermatitis Society
 American Contact Dermatitis Society Medical/Nursing ServicesHealth Services The American Contact Dermatitis Society promotes, supports, develops, and stimulates information about contact dermatitis and occupational skin disease. The private company is based in Bunnell, FL. | Health Services |
American Academy of Dermatology
 American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Commercial Services |
The New York Academy of Medicine
 The New York Academy of Medicine Miscellaneous Commercial ServicesCommercial Services The New York Academy of Medicine (NYAM) is a leading advocate for innovation in public health. The non-profit company is based in New York, NY and has subsidiaries in the United States. For 176 years, NYAM has been at the forefront of promoting bold changes to the systems that perpetuate health inequities and prevent communities from achieving good health. NYAM's work includes innovative research, programs, and policy initiatives that value community input for maximum impact. NYAM's library is one of the most significant historical libraries in medicine and public health in the nation, with an extensive range of recommended resources available. | Commercial Services |
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. The firms late-stage product candidate KD025, which is an orally administered selective inhibitor of Rho-associated coiled-coil kinase engages in development for the treatment of inflammatory and fibrotic diseases. The firm's a pivotal clinical trial of KD025 is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 clinical trial in systemic sclerosis. It is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. The company's lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein. Kadmon was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY. | Health Technology |
Brickell Subsidiary, Inc.
 Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
NYU Langone Health
 NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Technology Services |
Evommune, Inc.
Evommune, Inc. Miscellaneous Commercial ServicesCommercial Services Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA. | Commercial Services |
